This event will explore the revolutionary advances in genome editing, a field that took a leap forward with the work on CRISPR-Cas9, for which Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in 2020.
Event Details:
Date: Wednesday, November 13th, 2024
Time: 11:30 AM – 2:00 PM
Location: Spartners, 22 Route 128, Gif-sur-Yvette
Agenda:
- Panel Discussion: 11:30 AM – 1:00 PM (Speakers and detailed description below👇)
- Lunch & Networking: 1:00 PM – 2:00 PM
The discussion will feature the following speakers:
- Dr Pablo Bartolucci, MD, PhD Head of the Red Blood Cell Unit, Sickle cell referral center at Henri Mondor Hospital,
- Emmanuelle Billon Denis, PhD, CBRN Defense Architect – Open Innovation Manager at the French Defense Procurement Agency (DGA),
- Algenscribe a cutting-edge biotechnology company developing a genome editing platform aimed at improving human health.
Moderator:
- 🎤 Hélène Virasith, Program Manager, Genopole
Description:
We will kick off the event with a presentation on Casgevy, the groundbreaking therapy developed by Vertex Pharmaceuticals. Casgevy is the first and only treatment using CRISPR-Cas9 technology to receive FDA approval for treating sickle cell disease. To highlight the incredible potential of this therapy, we will hear from Professor Pablo Bartolucci, who will share his insights as a French clinician and discuss the promising future it offers to patients affected by this condition.
Next, we will welcome Algenscribe, an innovative startup pioneering an alternative DNA editing technique. While we are excited to learn more about their cutting-edge approach to gene therapy, the specific speaker from Algenscribe is yet to be confirmed.
The event will conclude with Emmanuelle Billon-Denis addressing the biological and defense-related risks associated with genome-editing technologies. She will open the floor for a thought-provoking discussion on the security challenges that arise from these advancements.
This promises to be a fascinating event where leading experts explore the future of gene therapy and the obstacles ahead. Attendees will have the chance to engage in a lively debate following the presentations and continue the conversation over a networking lunch. You are also invited to tour our brand-new laboratories, where innovative startups are pushing the boundaries of biotech.
